Paper · 1997
Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
PubMed, 82(6), 668–675 · Published 1 November 1997
In brief
“Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” is a 1997 paper by Rafael de la Cámara and 7 co-authors, published in PubMed. OpenAlex counts 23 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 23
- Most cited in
- 2024 (2)
- Field-weighted impact
- 0.58
- References
- 23
- Authors
- 8
Abstract
BACKGROUND AND OBJECTIVE: Meropenem is the first of a new class of carbapenems which may be administered without cilastatin. This study was performed to assess the clinical efficacy and tolerability of meropenem monotherapy (1 g/8 h) compared with the standard combination of ceftazidime (2 g/8 h) plus amikacin (15 mg/kg/day) for the empirical treatment of… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
de la Cámara, R., Figuera, A., Sureda, A. M., Hermida, G. J., Verge, G., Olalla, I., Rañada, J. F., & Domingo-Albós, A. (1997). Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study. PubMed, 82(6), 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087
MLA 9
de la Cámara, Rafael, et al. “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” PubMed, vol. 82, no. 6, 1997, pp. 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087.
Chicago
de la Cámara, Rafael, Angela Figuera, Anna Maria Sureda, Gerardo Julio Hermida, G Verge, Ignacio Olalla, J.M. Fernández Rañada, and A Domingo-Albós. 1997. “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.” PubMed 82 (6): 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087.
Harvard
de la Cámara, R. et al. (1997) ‘Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.’, PubMed, 82(6), pp. 668–675. Available at: https://pubmed.ncbi.nlm.nih.gov/9580087.
IEEE
R. de la Cámara et al., “Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.,” PubMed, vol. 82, no. 6, pp. 668–675, 1997.
BibTeX
@article{delacamara1997meropenem,
title = {{Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.}},
author = {de la Cámara, Rafael and Figuera, Angela and Sureda, Anna Maria and Hermida, Gerardo Julio and Verge, G and Olalla, Ignacio and Rañada, J.M. Fernández and Domingo-Albós, A},
journal = {PubMed},
year = {1997},
volume = {82},
number = {6},
pages = {668--675},
url = {https://pubmed.ncbi.nlm.nih.gov/9580087}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 1 | |
| 2015 | 1 | |
| 2018 | 1 | |
| 2019 | 1 | |
| 2021 | 1 | |
| 2024 | 2 | |
| 2026 | 1 |
Its field-weighted citation impact is 0.58: it has been cited 0.58 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- meropenem
- ceftazidime
- amikacin
- febrile neutropenia
- neutropenic cancer patients
- empirical antibiotic therapy
- carbapenems
- bone marrow transplant recipients
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
de la Cámara, R., Figuera, A., Sureda, A. M., Hermida, G. J., Verge, G., Olalla, I., Rañada, J. F., & Domingo-Albós, A. (1997). Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study. PubMed, 82(6), 668–675. https://pubmed.ncbi.nlm.nih.gov/9580087
How many times has this paper been cited?
23 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Rafael de la Cámara, Angela Figuera, Anna Maria Sureda, Gerardo Julio Hermida, G Verge, Ignacio Olalla, J.M. Fernández Rañada, A Domingo-Albós.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.